poae DNA at lower concentrations, although a more sensitive rDNA-

poae DNA at lower concentrations, although a more sensitive rDNA-based TaqMan assay was applied. The differences obtained can Selleck KU-60019 most probably be explained by the increased amplification efficiency (98.5–99.8%) of the esyn1-based

TaqMan assay used in this study, which resulted in higher amplicon levels quantified in comparison with previous studies, where the amplification efficiency of the assay used was 91%. Additional qualitative PCR analyses with species-specific primers for F. avenaceum (Turner et al., 1998) and F. tricinctum (Kulik, 2008) were performed in order to detect the presence of F. avenaceum and F. tricinctum in the samples analyzed. The results showed that F. avenaceum was only present in all samples harvested in 2007 where higher amounts of enniatins were detected, while the presence of F. tricinctum was revealed in all samples analyzed (data not shown). These results support the previous results of the studies of Logrieco et al. (2002) and Jestoi et al. (2004a, b) showing that F. avenaceum is responsible to a large extent for the increase in the enniatins content in grain samples. It seems that F. poae and F. tricinctum are the most frequent contaminants of wheat with low enniatins levels, DAPT in vitro even if environmental conditions did not promote the development of FHB. Although several studies demonstrated

correlations between Fusarium DNA and the mycotoxin concentration in cereal samples, it should not be assumed that the amount of genes of interest would in each case relate to the level of corresponding mycotoxins. Recent studies by Jurado et al. (2008) and Marín et al. (2010) demonstrated that the expression of genes involved in mycotoxin synthesis depends on different environmental factors. Additionally, the fungal strains can synthesize mycotoxins at different concentrations (Bakan et al., 2002). On the other hand, discrepancies between chemical and DNA-based methods may

result from the ability of plants to hide fungal toxins such as glucosides (Berthiller et al., 2005), although, to date, no glucosylation Florfenicol or other conjugation process is known for enniatins. Yli-Mattila et al. (2006, 2008) found a correlation between the levels of F. avenaceum and F. poae DNA analyzed using the TaqMan assay and enniatins in highly contaminated barley grain samples, although the correlation was not confirmed in samples with lower amount of mycotoxins. Similarly, in our previous studies, no correlation was revealed between F. poae DNA and the levels of enniatins in asymptomatic wheat samples with very low levels of enniatins (Kulik & Jestoi, 2009). In this study, Pearson’s correlation analyses were used to determine whether the amounts of esyn1 genotypes were related to the total amount of enniatins. A significant positive correlation was found between the amount of F. avenaceum/F. tricinctum esyn1 genotype (R=0.61, P=0.00001) and the total amount of enniatins (Fig. 1). In the case of F.

[18] These findings may show that the risk of acquiring acute hep

[18] These findings may show that the risk of acquiring acute hepatitis is higher among www.selleckchem.com/products/pexidartinib-plx3397.html long-term travelers. However, as our data are limited to Israeli travelers and further data is lacking, more evidence is required to confirm this observation. The main limitation of this study is the distinct

travel patterns of Israeli travelers that may be different from those traveling from other countries such as those in Western Europe or North America. Therefore, further studies are needed before applying our results to other traveler populations. In conclusion, acute hepatitis possesses a threat to travelers. In this cohort, 1% of ill Israeli travelers

were diagnosed with acute hepatitis. Enterically transmitted hepatitis is the main cause of viral hepatitis among these travelers. HEV is an emerging disease and has become the most common hepatitis among Israeli travelers. Although an efficacious vaccine has been developed, licensed HEV vaccine is not yet available. Efforts to develop an efficacious HEV vaccine for travelers are warranted. Despite the available HAV vaccine, there is a steady prevalence of HAV cases. Further follow-up is needed to determine whether the Israeli national program for HAV vaccination in infancy will affect the epidemiology of hepatitis among travelers. The authors state they have no conflicts of interest to declare. “
“15th Ed , 188 pp , paperback Dynein with illustrations, AUD24.95 , ISBN 978-0-9577179-2-3. MG-132 cost Brisbane , Australia: Dr. Deborah Mills , 2008 . http://www.drdeb.com.au . The United Nations World Tourism Organisation announced that there were a record

924 million international tourist arrivals in 2008.1 It is known that many travelers encounter some kind of health and safety problem whilst they are traveling. Travel health advisers are required to discuss the epidemiology, management, and prevention of the gambit of disease and injury hazards that may be confronted by travelers. There is a need to provide written material to travelers to help reinforce this advice, which can be assisted by a range of travel health reference publications available today specifically designed for travelers. The 15th edition of Travelling Well is one of these specialized references and one which has established itself as one of the leading educational aids in travel medicine in Australasia. Travelling Well, four pages shorter than the previous edition and with a host of minor revisions/updates, is presented as an A5 publication with an attractive, full-color, glossy travelogue cover. Travelling Well promotes itself well in the opening sections.

Patients managed in the drug conservation arm were at greater ris

Patients managed in the drug conservation arm were at greater risk of cardiovascular events than patients in the viral suppression arm receiving continuous therapy. This risk was associated with elevated markers of inflammation and coagulation in patients off treatment [26]. Several studies have focused on endothelial function, vascular endothelial activation and

inflammation in HIV-infected patients. FMD has been shown to be consistently impaired compared with uninfected controls [8, 9, 27, 28], but was normal in HIV-positive patients receiving treatment [10, 29]. However, these studies were all cross-sectional, which increased the variation and consequently decreased the sensitivity. Furthermore, the inclusion of active smokers may skew the data, because smoking is known to reduce FMD [13]. In a few studies where impairment of endothelial function was demonstrated Staurosporine in treatment-naïve patients [30, GSK-3 activation 31], improvement was seen when treatment was instituted [30]. This is in agreement with the present study, in which endothelial function was prospectively assessed. Although treatment resulted in an increase in total cholesterol, this did not negate the beneficial effects of treatment. Different markers of endothelial activation have been measured in both treated and nontreated patients.

ICAM and VCAM levels were higher in treated patients than in HIV-negative controls [32], whereas P-selectin, VCAM and vWF were elevated in untreated HIV-infected patients [33]. A significant drop in the latter two markers, but not in P-selectin, Carbachol was seen during treatment for 24 months. Kristoffersen et al. demonstrated elevated ICAM-1, but not VCAM-1 or E-selectin, in treatment-naïve patients; all markers, however, were reduced during treatment [34]. Mastroianni et al. reported lower L-selectin, but not E-selectin, and lower ICAM-3 and VCAM-1, but not ICAM-1, during treatment [35]. The results from the latter study are discordant with our findings, although both indicate that the vasculature is activated prior to treatment, and that

HAART modifies this activation. A PI-based regimen was used throughout by Mastroianni et al., and the PIs used were different from those used in our study. As regards inflammatory markers, the published studies disagree. One group reported elevated CRP levels in treatment-naïve patients, the level decreasing during treatment [34], whereas CRP levels were found to be higher in treated than in untreated HIV-infected patients in another cross-sectional study [36]. Fibrinogen was elevated in treatment-naïve patients and declined during treatment. However, comparing treatment strategies, levels were significantly higher with PI-based HAART than in NNRTI-treated patients [37]. We found a gradual decline in fibrinogen during treatment, with the lowest levels seen during treatment with efavirenz.

Univalent analysis of

Univalent analysis of 5FU covariates previously reported to affect efavirenz

exposure, including gender, age, weight and total bilirubin, was performed. In the light of the results of a previous study, in which we found that HIV-infected patients had a lower relative bioavailability of efavirenz compared with health volunteers [11], the effects of parameters that change with HIV disease, including CD4 cell count, viral load and albumin level, were also analysed. A total of 66 patients were recruited for the study, of whom 63.6% were female. The mean age of the participants was 38.3 (standard deviation 10.9) years, and their mean weight was 51.7 (standard deviation 9) kg (Table 1). Of the 66 patients recruited, 52 had complete NCA results for day 1, 55 had complete NCA results for day 14, and 43 had complete NCA results for both days. For the remainder of the patients (14 patients for day 1, 11 for day 14 and

23 for days 1 and 14 combined), the elimination phases did not contain a sufficient number of efavirenz plasma concentration time-points to enable calculation of clearance, although other parameters, including Cmax, Cmin and tmax, were determined. The mean efavirenz Cmin on day 14 was 2.9 µg/mL, with only 4.5% of patients having subtherapeutic minimum concentrations. The mean Cmax and AUC were observed to approximately double over the 14-day period, while average clearance remained unchanged. The effect of covariates on efavirenz exposure was explored for both study days, and, although various covariates were PF-562271 research buy examined, including gender, CD4 cell count, viral load and total bilirubin level, only albumin showed a negative correlation with efavirenz exposure on day 1 of treatment. The mean AUC and Cmax on day 1 were higher in patients with low albumin levels than in patients with normal albumin levels (P=0.034 and 0.023 for AUC and Cmax, respectively). For two participants (ID10 and ID11), the AUC (6.8 and 10.4, respectively) and volume of distribution (2925 and 2601 L, respectively) were found to be outliers using Grub’s

MTMR9 test for outliers, and their parameters were not included in the calculation of the mean of the population. Table 2 shows results for mean pharmacokinetic parameters in the study population. Although the population mean clearance did not change significantly over the first 2 weeks of treatment, 41.9% of patients with complete data for days 1 and 14 (n=43) showed an average 95.8% (range 1–423%) increase in clearance between the two study days, while the remainder of the participants experienced either no change or a reduction in clearance. Following this observation, an analysis was performed to look for any difference in day 14 efavirenz concentration between the group that exhibited autoinduction and the group that did not.

As illustrated in our study, malaria remains

As illustrated in our study, malaria remains Ixazomib a priority. This tropical disease should always be ruled out in travelers returning from an endemic area and presenting neurological impairments. Like in the recent travel-associated pathologies series,2–8,10–12 we also observed that cosmopolitan etiologies were the leading cause of travel-related CMI. Enteroviruses are the most common cause of viral meningitis (and less commonly of encephalitis) in the general population.13 Our study showed that they should also be considered as the most likely cause of CMI in a

traveler, even in a tropical country, as enteroviruses are food-borne agents.14,15 Herpes viruses should also always be suspected in travel-related CMI, particularly the herpes simplex virus 1 (HSV-1) which remains the first cause of encephalitis in adults (HSV-2 is especially responsible for DNA Synthesis inhibitor meningitides) with a fatal outcome if not treated rapidly (28% lethality rate the first year).16 Thus, HSV-1 should be thoroughly sought for and acyclovir quickly and empirically

started in travelers with suspected viral encephalitis while awaiting viral diagnostic studies. We also reported two cases of HIV primary infection occurring as acute meningitis. Due to the incidence rate of high risk sexual behaviors in travelers (5–50% depending on the traveler’s profile and destination), HIV acute infection should be considered in a clinical presentation of feverish headaches or unexplained central nervous system Ribociclib datasheet manifestations.17 Another interesting observation was the case of Toscana virus meningitis in a patient returning from Italy. The incidence of this arboviral disease has been increasing in travelers to the Mediterranean basin in recent years.18 This example illustrates the growing risk of importing specific European pathogens. The only case of meningococcal meningitis was contracted in Germany

by a student. This potentially fatal CMI is rare in the traveler. Besides the classic risks such as traveling to the African meningitis belt or the Saudi Arabia hajj,19 practitioners should also be aware of travelers who lived abroad in institutions or communities.20 In our study, blood smear and lumbar puncture were the main biological investigations, allowing the diagnosis of CMI in 55 cases. Other routine blood tests did not seem discriminating, such as CRP that was not a specific test in the diagnostic assessment of a CMI (it was high in 42% of the confirmed viral CMI). Thus, the measuring of procalcitonin serum level (unused in our study) could be useful in the distinction between bacterial and viral etiologies.21 The CSF analysis should be interpreted cautiously as polymorphonuclear leukocytosis or decreased glucose concentration is not synonymous with bacterial meningitis.

3 and 32 times higher in the co-culture and B cepacia culture m

3 and 3.2 times higher in the co-culture and B. cepacia culture medium than the fungal culture on the third day. The peak enzymatic SB431542 activity was observed on the sixth day. Subsequently, the acid phosphatase activity of the medium grown with A. niger and co-culture did not change, and the activity of the medium grown with bacteria declined enough. In general, a significant correlation was observed between the variables studied (Table 2). Solubilized phosphate showed a significant positive correlation with titratable acidity and a significant negative correlation with pH and glucose content. Significant negative correlations were also observed between titratable acidity and pH, as well as between glucose and pH. CaP was

more efficiently solubilized in media wherein A. niger–B. cepacia were co-cultivated, in comparison with single cultures. This is the first report of joint utilization of CaP by two PSM in vitro. The results presented here clearly

depict that co-culture of these microorganisms is mutually beneficial and results in enhanced quantities of soluble P produced in the growth medium. Extent of phosphate solubilization by A. niger and B. cepacia click here have previously been reported as 1394 μg P2O5 mL−1 (Rinu & Pandey, 2010) and 200 μg mL−1 (Lin et al., 2006) or 346 μg mL−1 (Song et al., 2008), respectively. The quantity of phosphate solubilized on the ninth day by B. cepacia was 0.86 mg   mL−1 and by A. niger was 10.07 mg  mL−1. These results demonstrate that both microorganisms were highly efficient at solubilizing phosphate with ES rates of 78% and 91%, respectively. Previous results have demonstrated ES rates ranging from 42 (Vassileva et al., 1998), 47 (Rinu & Pandey, 2010), and 54% (Omar, 1998) using A. niger in culture media. However, our results demonstrate that the A. niger–B. cepacia co-culture solubilized 1.10 mg  mL−1 and yielded ES rates of 100%, higher than that obtained by either single culture. A plausible hypothesis is that synergism between the fungus and bacteria may have caused considerable improvement in growth and phosphate solubilization.

The activity of PSM in vitro generally correlates with various factors, most importantly, the release ADP ribosylation factor of organic acids, which subsequently decreases the pH of the growth medium (El-Azouni, 2008; Kang et al., 2008; Song et al., 2008; Park et al., 2010). Similar trends were observed in this study. In addition, we observed that differences in growth rate influenced the production of acid, the reduction in pH, and consequently, the solubilization of phosphate. Rapid growth was observed during the initial period of incubation; for B. cepacia and the co-culture, this was 3 days and for A. niger, 6 days. High rates of bacterial and fungal growth in phosphate solubilization assays have also been reported in other studies (Lin et al., 2006; Saber et al., 2009). Phosphate solubilization by both single cultures as well as the co-culture correlated significantly with production of acid (0.

Following incubation, propidium iodide (1% v/v) was added and hem

Following incubation, propidium iodide (1% v/v) was added and hemocytes incubated in the dark for an additional 30 min. Samples were then analyzed with a FACS-Calibur™ flow cytometer (Becton Dickinson). The measures were obtained after 30 s with a low flow rate. The three replicate data

collected were then statistically analyzed by a one-way anova, with P-error level set at 0.05. The sensitivity to antibiotics was determined by a disc-diffusion method according to the AFNOR NF U47-106 instructions, with Marine Agar plate as medium due to marine bacteria cultivability. Antibiotics tested were amoxicillin (25 μg), colistin (50 μg), Lenvatinib enroflaxin (5 μg), florfenicol (30 μg), flumequin (30 μg), tetracycline (30 UI) and trimethroprim/sulphamethoxazole (1.25/23.75 μg). Results were observed after an 18–20-h incubation at 18 °C. The haemolymph from oysters, clams, mussels and scallops were spread onto non-selective Marine www.selleckchem.com/products/pf-562271.html Agar. A great disparity in culturable haemolymph-associated bacteria was observed intra host species (data not shown). Haemolymph bacterial concentrations below the lower limit of detection

(i.e. 102 CFU mL−1) were more frequently observed in mobile bivalve (75% of P. maximus and 51% of Tapes rhomboides collected) than in haemolymph from fixed bivalves (9% of C. gigas and M. edulis collected). Excluding these extreme bacterial concentrations, the highest average bacterial concentration was detected in M. edulis haemolymph and the lowest one in P. maximus (Table 2).The culturable haemolymph-associated bacterial concentrations were shown to be individual- and species-dependent

(Table 2). This may be the result of various environmental concentrations (Olafsen et al., 1993) as well as bivalve physiological characteristics. Moreover, growth conditions (MB medium and incubation temperature) may clearly impact the bacterial growth rate and/or select some marine species (Gram et al., 2010). A total of 843 haemolymph-associated strains were isolated from the bivalve haemolymph sampling (Table 2). They Fenbendazole were named according to their origin and the number of the isolate. For instance, the hCg-1 strain was the first strain isolated from C. gigas haemolymph. The 843 isolates were screened for antibacterial activity against 12 target bacteria by the well-diffusion assay. Among these, 26 isolates (about 3%) showed a clear inhibition zone around wells for at least one target strain (Table 2). The antibacterial activity was exclusively directed against Gram-negative bacteria, mostly of the Vibrio genus. Such selectivity of activity differs from the antibacterial spectra usually described during marine antibiotic screenings. Indeed, Gram-positive target bacteria generally appear to be more sensitive (Hughes & Fenical, 2010; Wilson et al., 2010).

, 1984) CysK forms the cysteine biosynthesis enzyme complex with

, 1984). CysK forms the cysteine biosynthesis enzyme complex with CysE, together converting l-serine to l-cysteine via O-acetylserine. The cysK gene is under the control of CysB, a LysR-type family transcriptional factor (Monroe et al., 1990; Hryniewicz & Kredich, 1994; Byrne et al., 1998). CysB senses N-acetylserine and activates transcription of not only cysK but also a number of genes involved in

sulfur utilization and sulfonate-sulfur catabolism, including cbl (Iwanicka-Nowicka & Hryniewicz, 1995), cysDNC (Kredich, 1992; Leyh et al., 1992), cysJIH (Monroe et al., 1990), cysK (Monroe Selisistat price et al., 1990), cysPUWAM (Lochowska et al., 2001, 2004), and tauA (van der Ploeg et al., 1997). CysB is negatively autoregulated (Ostrowski & Kredich, 1991). In the absence of effector ligand, CysB also repressed hslJ involved in novobiocin resistance and ssuEADCB involved in transport and metabolism

of alphatic sulfonate (van der Ploeg et al., 1999; Bykowski et al., 2002). Expression of cysK is also activated by an as yet uncharacterized extracellular signal(s) present in Escherichia coli culture media (Baca-DeLancey et al., 1999). Recently we found that several metal ions affect the expression of cysK gene (Yamamoto & Ishihama, 2005a,  b; Hobman et al., 2007). As an extension of this line of studies, we identified in this study several genetic and BIBF 1120 mouse environmental factors for induction of the cysK gene. Based on all the findings herein described, we succeeded to construct a 12-fold higher expression system of cysK, that can be employed for high-level production of cysteine. The strains used in this study are listed in Table S1. Escherichia coli strains containing a single copy of lacZ fusion gene on the genome were constructed

according to Simons et al. (1987). The plasmid derived from pRS551 and pRS552 (see below for plasmid construction) was transformed into MC4100 (Casadaban, 1976). The transformant was infected with λRS45 to prepare λ lysate including either the recombinant phage containing lacZ fusion gene. Host E. coli was infected with the lysate, and the lysogen containing the recombinant λ phage was selected by resistance to kanamycin. To construct lacZ fusion gene, pRS551 and pRS552 plasmids were used as vectors (Simons et al., 1987). The promoter fragment was amplified by PCR using the genome of E. coli W3110 type-A strain (Jishage & Ishihama, 1997) as a template and a pair of oligonucleotides (Tables S2 and S3). The PCR product was digested with BamH I and EcoR I and then ligated into pRS551 or pRS552 at the corresponding sites. DNA sequence of insertion on plasmids was confirmed by DNA sequencing using Lac30R primer complementary to lacZ orf.

, 2004) Rhizobium leguminosarum swarm cells are also characteriz

, 2004). Rhizobium leguminosarum swarm cells are also characterized by an increase in flagellation in 3841 and hyperflagellation in VF39SM. The hyperflagellation observed in VF39SM swarm cells is coupled with an increased expression of flagellin genes. Hyperflagellation of swarmer cells has been demonstrated in a number of bacteria including Vibrio parahaemolyticus (McCarter, 1999), P. mirabilis (Allison et al., 1993), R. etli (Braeken et al., 2008), E. coli, and Salmonella typhimurium (Harshey & Matsuyama, 1994). We also looked at the expression of the transcriptional activators VisN and Rem under swarming conditions. We have shown in a previous study that VisN is a transcriptional activator of rem, while

Rem regulates the expression of a subset of flagellin genes in R. leguminosarum (Tambalo et al., 2010). It appears that the upregulation of flagellin synthesis for R. leguminosarum swarmer http://www.selleckchem.com/products/i-bet-762.html this website cells occurs at the level of the transcriptional activator VisN because increased expression was also observed for visN under swarming conditions. This type of regulation is similar to what has been reported

in P. mirabilis, where the expression of the master regulator FlhDC increased 30-fold in swarmer cells (Fraser & Hughes, 1999). Although slightly higher, the expression of rem under swarming conditions was very similar to cells grown in liquid media. It is possible that Rem is involved in the activation of motility-related genes under both swimming and swarming conditions. There might also be additional transcriptional activators of flagellar genes under swarming conditions, aside from Rem, thus Chlormezanone the observed upregulation of flagellin genes in swarmer cells. We demonstrated

that a nutrient-rich medium is essential for surface migration in R. leguminosarum. Without supplementation of a carbon source to the basal swarm medium, swarming motility was significantly reduced. We have shown that differentiation into swarm cells involves increased flagellation. Because flagellar synthesis and function is energetically costly (Wei & Bauer, 1998; Soutourina & Bertin, 2003), we speculate that a significant amount of energy is needed for differentiation, thus the need for an energy-rich medium. In addition, the supplemented sugar might be metabolized by the bacteria to produce the extracellular matrix. Plasmid-cured strains that are unable to metabolize the sugar did not swarm and they formed dry colonies, which could indicate the absence of the extracellular matrix that is needed for surface translocation. Although swarming motility is not dependent on the type of carbon source used, VF39SM exhibited slightly different swarming patterns using different types of carbon sources. The differences in the swarming patterns could be attributed to the different types and amounts of extracellular slime produced using these carbon sources. Rhizobium leguminosarum swarmed faster in mannitol compared with glycerol (data not shown).

2) The lengths of these fragments could be compared with virtual

2). The lengths of these fragments could be compared with virtual fragment PARP inhibitor lengths generated on the basis of 118 complete sequences available

in GenBank. The lengths of the first, second and third restriction fragments corresponded to the virtual fragments in lengths equal to 141–144, 238–241 and 114–120 bp, respectively. Three (2.6%) virtually cleaved sequences of T. aestivum bore one additional TaiI restriction site, resulting in abnormal restriction patterns: 35, 107, 240 and 119 bp fragments (AJ888116) or 142, 25, 215 and 117 bp fragments (AJ888110 and AJ888109). TaiI restriction profiles of all the 52 analyzed T. aestivum samples were identical to those presented in Fig. 2. TaiI virtual cleavage of Tuber mesentericum resulted in a large fragment of approximate lengths Navitoclax 356, 323 or 485 bp and a very short 6-bp 3′-terminal fragment. In most sequences, 136- or 131-bp fragments were also produced, and in some sequences, 27-bp fragments were generated. A large band (approximately 350 bp in Fig. 2, corresponding to a 356-bp virtual fragment) obtained from T. mesentericum clearly separated this species from T. aestivum possessing a doublet of shorter fragments. We could generate virtual

restriction fragments using only 16 GenBank sequences of T. mesentericum, as the sequences of ITS1 and ITS2 spacers obtained from T. mesentericum containing specimens have been mostly published separately and lack the overlapping region. Reconstruction of the ITS region in Chlormezanone these cases was therefore impossible. However, the comparison of restriction motif locations in 250 such sequences with those in sequences used for generation of virtual fragments revealed a very high degree of similarity, which indicates that the abovementioned virtual fragment lengths are highly conserved. In field-collected soil samples (Fig. 3), T. aestivum restriction fragments were detected in all cases except for sample 1, which is the most distant one in terms of the locations of the fruit body finds. Samples 1, 2, 4, 5 and 8 gave no positive T. aestivum signal with DNA extracted from ectomycorrhizae. These negative results were not consistent with the occurrence

or absence of burnt (brûlé) soil areas, whose locations are indicated in Fig. 1. DNA amplified from positive samples 3, 6, 7 and 9 was sequenced and the identity of T. aestivum as mycorrhiza component was confirmed by comparison with GenBank data in all cases. Recommended protocols for detection of T. aestivum in ectomycorrhizae and in soil, as well as the results of the sensitivity test of nested PCR, are given in Appendix S5. Molecular identification and detection of truffles is in the focus of commercial interests producing certified high-quality inoculated tree plantlets. For example, a considerable effort has been invested into molecular differentiation of T. aestivum and T. aestivum forma uncinatum (Mello et al., 2002; Paolocci et al., 2004).